Pancreatic Cancer Research

ResearcherCentral South UniversityActive in the last 2 years

Xi Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-8548-2832; OpenAlex author ID A5100430853, A5122317641. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 2

  1. Downregulation of NFIA facilitates glycolysis, histone lactylation, and activation of the FN1-integrin α5β1 pathway in pancreatic cancer. Co-author DOI 10.1007/s10495-025-02218-6↗
  2. MicroRNA-23a promotes pancreatic cancer metastasis by targeting epithelial splicing regulator protein 1. Co-author DOI 10.18632/oncotarget.20692↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zewen Song · 1 shared paper, 2026 · strength 0.29
  2. Yingqiang Xu · 1 shared paper, 2017 · strength 0.08
  3. Guo Wu · 1 shared paper, 2017 · strength 0.08
  4. Peng Jiang · 1 shared paper, 2017 · strength 0.08
  5. Zhonghu Li · 1 shared paper, 2017 · strength 0.08
  6. Xiaowu Li · 1 shared paper, 2017 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.